BERTOLINI, ANDREA
 Distribuzione geografica
Continente #
EU - Europa 166
NA - Nord America 148
AS - Asia 45
Totale 359
Nazione #
US - Stati Uniti d'America 147
PL - Polonia 52
IT - Italia 51
SE - Svezia 21
IE - Irlanda 20
HK - Hong Kong 17
CN - Cina 12
CH - Svizzera 8
RU - Federazione Russa 7
SG - Singapore 6
JO - Giordania 4
VN - Vietnam 4
GB - Regno Unito 3
FR - Francia 2
KR - Corea 2
CA - Canada 1
DE - Germania 1
FI - Finlandia 1
Totale 359
Città #
Warsaw 52
Dublin 20
Fairfield 20
Chandler 14
Hong Kong 12
Ashburn 11
Scandicci 10
Cambridge 9
Florence 9
Seattle 9
Bern 8
Lawrence 8
Altamura 7
Moscow 7
Carrara 6
Woodbridge 6
Boston 5
Houston 5
Kent 5
Princeton 5
Shanghai 5
Singapore 5
Ann Arbor 4
Beijing 4
Dong Ket 4
New York 4
Wilmington 4
Buffalo 3
Senigallia 3
Campobasso 2
Hillsboro 2
Poggibonsi 2
Prescot 2
Redwood City 2
Saint-Fons 2
Seoul 2
Bremen 1
Edmonton 1
Falls Church 1
Fiesole 1
Greve in Chianti 1
Lappeenranta 1
London 1
Medford 1
Norwalk 1
Prato 1
Rome 1
San Diego 1
Turin 1
Washington 1
Totale 292
Nome #
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial 92
Tuberomics: A molecular profiling for the adaption of edible fungi (tuber magnatum pico) to different natural environments 85
Phagocytosis and ACTH-like and β-endorphin-like molecules in invertebrate (molluscan) and in vertebrate (human) cells. Possible significance for the evolution of the immunoneuroendocrine system 47
A biomimetic enzyme-linked immunosorbent assay (BELISA) for the analysis of gonadorelin by using molecularly imprinted polymer-coated microplates 47
The Advanced Virgo+ status 32
The present study investigated the effect of allopregnanolone (5α-pregnan-3α-ol-20-one) or of passive immunoneutralization of brain allopregnanolone, the most potent steroid produced by neurons, on ovulation rate and sexual behavior in female rats. Allopregnanolone was injected intracerebroventricularly in rats on diestrus and proestrus and tests were done on estrus. The intracerebroventricular injection of allopregnanolone significantly decreased the number of oocytes collected on estrus (p < 0.01). To support a physiological involvement, antiserum to allopregnanolone was injected centrally to block the activity of the endogenous neurosteroid. When administered on diestrus and proestrus or only on proestrus, the antiserum was shown to be correlated with a significant increase (p < 0.01) in oocytes retrieved on estrus. In female rats treated with antiserum to allopregnanolone, the lordosis intensity was augmented significantly as compared to controls. Finally, the possible changes of medial basal hypothalamus concentration of allopregnanolone throughout the estrous cycle and at the time of ovulation were investigated. Hypothalamic extracts were eluted on highpressure liquid chromatography and allopregnanolone concentration was measured by radioimmunoassay. Brain cortex was used as control tissue. Hypothalamic allopregnanolone concentration on proestrus morning and afternoon was found to be significantly lower than in the remaining phases of the estrous cycle (p < 0.01), while no significant changes were observed in brain cortex concentration of allopregnanolone. The present results suggest that hypothalamic allopregnanolone may be involved in the mechanism of ovulation, affecting hormonal and behavioral events. 29
Open Data from the Third Observing Run of LIGO, Virgo, KAGRA, and GEO 20
Advanced Virgo Plus: Future Perspectives 14
Serotonin-Derived Fluorophore: A Novel Fluorescent Biomaterial for Copper Detection in Urine 3
Long-term outcome of a cohort of Italian patients affected with alpha-Mannosidosis 1
Totale 370
Categoria #
all - tutte 2.200
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.200


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202030 3 1 0 1 2 3 2 2 2 1 12 1
2020/202183 9 8 2 13 5 7 6 7 6 10 5 5
2021/202246 0 3 0 4 1 0 1 6 0 4 5 22
2022/2023119 6 23 8 3 2 16 13 1 16 17 5 9
2023/202481 1 5 11 6 7 9 1 16 5 5 11 4
2024/202511 11 0 0 0 0 0 0 0 0 0 0 0
Totale 370